
HIROTSU Bio Science Inc. (Head Office: Chiyoda-ku, Tokyo; Representative; Takaaki Hirotsu (Hereinafter referred to as “HIROTSU”), is proud to announce the opening of a special “Users’ Voice” website on November 8, 2023, to provide feedback from customers who have experienced N-NOSE.
The number of users of the N-NOSE nematode cancer test in Japan has exceeded 500,000. We have received a variety of comments from many users. Some of the testimonials include, “By taking the test regularly, I was able to notice changes in my body,” “I had not had a physical checkup, so I decided to take the N-NOSE test as a simple first step,” and “I started to care about my health by taking the test every year on our anniversary as a married couple. In addition, there was a comment that a couple was able to find cancer after visiting a medical institution as a result of using N-NOSE.
We have opened a special Users’ Voices website in the hope that these valuable stories will lead to the early detection of cancer in as many people as possible. The site will feature real-life testimonials from people who have used N-NOSE and other N-NOSE services, including “N-NOSE Dogs”.
The new site is decorated with a wave pattern, similar to the N-NOSE package. We hope that by sharing our users’ experiences through this site, we can further expand the circle of early detection of N-NOSE.
TOKYO, JAPAN – March 6, 2026 – HIROTSU Bio Science Inc. announced the establishment of a new U.S. subsidiary, Hirotsu Global Inc., effectively c . . .
2026.03.06FOR IMMEDIATE RELEASE HIROTSU Bio Science Announces Referral of Former Employee to Prosecutors for Violation of the Unfair Competition Preven . . .
2026.02.05A novel, non-invasive approach to detecting micro-distant metastasis in highly lethal pancreatic cancer. TOKYO, JAPAN – January 5, 2026 – HIR . . .
2026.01.05